1 active not recruiting, 1 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
Follow GARDASIL® 9: new trials by email Literature Review of GARDASIL® 9 trials Research Report on GARDASIL® 9
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine Nonavalent HPV study vaccine, GARDASIL® 9 - Human Papillomavirus Infection | Phase 3 | Unknown | Beijing Health Guard Biotechnology, Inc | 1260 | 2023-11-21 | 2024-01-23 |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli), GARDASIL® 9 - Human Papillomavirus Infection | Phase 3 | Active not recruiting | Beijing Health Guard Biotechnology, Inc | 2750 | 2022-03-23 | 2022-12-27 |
| Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine), Meningococcal group A, C, W-135, and Y conjugate vaccine, Human Papillomavirus 9-valent Vaccine (9vHPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 463 | 2021-03-16 | 2025-09-12 |
Papillomavirus Infections (2) · Anus Neoplasms (1) · Condylomata Acuminata (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Beijing Health Guard Biotechnology, Inc (2) · Sanofi Pasteur, a Sanofi Company (1)
China (1) · Hungary (1) · Indonesia (1) · Italy (1) · Singapore (1) · Spain (1)
Yongjiang Liu, Bachelor (1) · Yu Hongyang (1)